HSU ERIC C
Insider CIK 1817867 · INM Sr. VP, Pre-Clinical Res/Dev
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2025-12-19 | 2025-12-19 | 13,000 | — | $0 | 18,280 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | H Expire deriv | 2025-12-15 | 2025-12-17 | 70 | — | $0 | 5,280 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2024-12-20 | 2024-12-23 | 2,750 | — | $0 | 5,350 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | H Expire deriv | 2024-05-27 | 2024-05-28 | 545 | — | $0 | 52,000 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | H Expire deriv | 2024-03-04 | 2024-03-05 | 309 | — | $0 | 52,545 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2023-12-23 | 2023-12-26 | 45,000 | — | $0 | 52,854 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | H Expire deriv | 2023-08-31 | 2023-08-31 | 327 | — | $0 | 7,854 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | H Expire deriv | 2023-05-16 | 2023-05-16 | 152 | — | $0 | 8,181 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | H Expire deriv | 2023-03-08 | 2023-03-09 | 545 | — | $0 | 8,333 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2022-12-16 | 2022-12-19 | 4,200 | — | $0 | 8,878 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2022-11-14 | 2022-11-15 | 4,200 | — | $0 | 8,878 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | D To issuer deriv | 2022-11-14 | 2022-11-18 | 4,200 | — | $0 | 4,678 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2021-10-18 | 2021-10-19 | 35,000 | — | $0 | 116,969 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | A Award deriv | 2020-12-16 | 2020-12-18 | 35,000 | — | $0 | 35,000 | SEC↗ |